Skandinaviska Enskilda Banken (SEB)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,000	Closed	-$93K	–	1010
2023 Q2	$93K	Buy	+2,000	New	+$69.1K	﹤0.01%	903

Skandinaviska Enskilda Banken (SEB)'s DICE Position: Q3 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,000 shares — an estimated $93K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $93K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Skandinaviska Enskilda Banken (SEB) reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 2,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $93K.
Skandinaviska Enskilda Banken (SEB) first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s DICE Therapeutics, Inc. Common Stock position peaked at $93K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2023, filed 9 Nov 2023.